Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01162031|
Recruitment Status : Withdrawn (no accrual)
First Posted : July 14, 2010
Last Update Posted : May 21, 2018
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||July 2011|